| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/29/2000 | US6110468 Respiratory syndrome virus for swine |
| 08/29/2000 | US6110467 Isolated porcine respiratory and reproductive virus, vaccines and methods of protecting a pig against a disease caused by a porcine respiratory and reproductive virus |
| 08/29/2000 | US6110466 Modified plant viruses as vectors |
| 08/29/2000 | US6110457 Single stranded rna hybrid virus |
| 08/24/2000 | WO2000049040A2 Antimicrobial/endotoxin neutralizing polypeptide |
| 08/24/2000 | WO2000049038A2 Synthetic peptide of regulatory virus protein r (vpr) of human immunodeficiency virus type 1 (hiv-1) and the utilization thereof |
| 08/24/2000 | WO2000048996A2 β-ALANINE DERIVATIVES |
| 08/24/2000 | WO2000048989A1 Mevinolin derivatives |
| 08/24/2000 | WO2000048643A1 Biodegradable, injectable oligomer-polymer composition |
| 08/24/2000 | WO2000048639A1 Immobilized labeling compounds and methods |
| 08/24/2000 | WO2000048638A2 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | WO2000048633A1 Antibodies against hydrophobic proteins that are protective against candidiasis |
| 08/24/2000 | WO2000048630A1 Immunogenic complexes and methods relating thereto |
| 08/24/2000 | WO2000048629A1 USE OF AN OmpA ENTEROBACTERIUM PROTEIN ASSOCIATED WITH THE ELAGIGILTV PEPTIDE FOR TREATING MELANOMAS |
| 08/24/2000 | WO2000048628A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | WO2000048624A2 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 08/24/2000 | WO2000048623A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | WO2000048620A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | WO2000048615A2 TREATMENT OF CHRONIC VIRAL INFECTIONS WITH $i(M. VACCAE) |
| 08/24/2000 | WO2000048610A1 Chemical compounds |
| 08/24/2000 | WO2000048609A1 Chemical compounds |
| 08/24/2000 | WO2000048607A1 Directly compressible matrix for controlled release of single daily doses of clarithromycin |
| 08/24/2000 | WO2000048603A1 DIBENZO-AZEPINE DERIVATIVES AS αV INTEGRIN RECEPTOR ANTAGONISTS |
| 08/24/2000 | WO2000048598A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/24/2000 | WO2000048571A1 Spontaneously dispersible n-benzoyl staurosporine compositions |
| 08/24/2000 | WO2000022134A3 Test kit for diagnosis of borrelia infection and novel borrelia antigens for the development of vaccines |
| 08/24/2000 | WO2000022113A9 ENZYMATIC SYNTHESIS OF ssDNA |
| 08/24/2000 | WO2000022112A9 Stabilized bioactive peptides and methods of identification, synthesis and use |
| 08/24/2000 | WO2000015251A3 Influenza virus vaccine composition |
| 08/24/2000 | WO2000010611A3 Drug targeting |
| 08/24/2000 | WO1999057280A3 Neisseria meningitidis antigens and compositions |
| 08/24/2000 | WO1999040938A3 Vaccines comprising interleukin-12 and herpes simplex viral antigen |
| 08/24/2000 | WO1998000439A3 Multivalent compounds for cross-linking receptors and uses thereof |
| 08/24/2000 | DE4193302C2 Verwendung rekombinanter Antikörper spezifisch für TNF-alpha Using recombinant antibody specific for TNF-alpha |
| 08/24/2000 | DE19908753A1 Oligomer-polymer composition containing biodegradable polymers of hydroxycarboxylic acids, useful as injectable implant for administration of various drugs |
| 08/24/2000 | CA2372059A1 Use of an ompa enterobacterium protein associated with the elagigiltv peptide for treating melanomas |
| 08/24/2000 | CA2371824A1 .beta.-alanine derivatives |
| 08/24/2000 | CA2371799A1 Yeast cell wall peptides and antibodies thereto |
| 08/24/2000 | CA2363670A1 Chemical compounds |
| 08/24/2000 | CA2362860A1 Immobilized labeling compounds and methods |
| 08/24/2000 | CA2362807A1 Multi-mutant diphtheria toxin vaccines |
| 08/24/2000 | CA2362664A1 Utilization of orosomucoid in order to produce a pharmaceutical preparation |
| 08/24/2000 | CA2362538A1 Secreted proteins and polynucleotides encoding them |
| 08/24/2000 | CA2362334A1 Dibenzo-azepine derivatives as .alpha.v integrin receptor antagonists |
| 08/24/2000 | CA2362306A1 Chemical compounds |
| 08/24/2000 | CA2362290A1 Novel amide derivatives as growth hormone secretagogues |
| 08/24/2000 | CA2362192A1 Use of an enterobacterium protein ompa associated with an antigen for generating an antiviral, antiparasitic or antitumoral cytotoxic response |
| 08/24/2000 | CA2361925A1 Treatment of chronic viral infections with m. vaccae |
| 08/24/2000 | CA2299117A1 Antimycotic compositions |
| 08/23/2000 | EP1029870A2 Hybrid Immunoglobulins |
| 08/23/2000 | EP1029854A1 Oxazolidinones and their use as antibacterial agents |
| 08/23/2000 | EP1029543A1 Therapeutic aqueous composition containing a hexahydro-5-pyrimidinamine compound and a polyalkoxylated fatty alcohol |
| 08/23/2000 | EP1029538A2 Soft gelatin capsule manufacture |
| 08/23/2000 | EP1029080A1 Human blood bacterium |
| 08/23/2000 | EP1029062A1 Inhibition of human immunodeficiency virus (hiv-1) replication |
| 08/23/2000 | EP1029061A2 Lysozym-analogous proteins and peptide having an anti-microbial activity, production of the same and use thereof |
| 08/23/2000 | EP1029054A1 Hp90: host membrane receptor for pathogenic bacteria, encoded by the bacterial tir gene |
| 08/23/2000 | EP1029052A2 Neisserial antigens |
| 08/23/2000 | EP1028977A2 Bifidus stimulating peptides |
| 08/23/2000 | EP1028975A1 Artemin, a novel neurotrophic factor |
| 08/23/2000 | EP1028964A1 Thienopyrimidine and thienopyridine derivatives useful as anticancer agents |
| 08/23/2000 | EP1028962A1 Carbapenem antibacterial compounds, compositions containing such compounds and methods of treatment |
| 08/23/2000 | EP1028961A1 Pleuromutilin derivatives as antimicrobials |
| 08/23/2000 | EP1028945A1 Substituted pyridine compounds as anti-inflammatory agents |
| 08/23/2000 | EP1028848A1 Prepolymer compositions comprising an antimicrobial agent |
| 08/23/2000 | EP1028750A1 Multivalent vaccines |
| 08/23/2000 | EP1028749A1 Enterococcus antigens and vaccines |
| 08/23/2000 | EP1028742A1 Host derived proteins binding hcv: medical, diagnostic and purification use |
| 08/23/2000 | EP1028739A2 Use of protein h as cytostatic agent |
| 08/23/2000 | EP0844873A4 Carotenoid-nicotinamide-zinc compositions and methods of treatment using same |
| 08/23/2000 | EP0805795B1 Novel aromatic amides, method for preparing and compositions containing same, and use thereof as pesticides |
| 08/23/2000 | EP0708772B1 IMIDAZO [4,5-c]PYRIDIN-4-AMINES |
| 08/23/2000 | CN1264425A Syncytial respiratory virus epitopes and antibodies comprising them, useful in diagnosis and therapy |
| 08/23/2000 | CN1264387A Nucleotide analog composition and synthesis method thereof |
| 08/23/2000 | CN1264382A Novel compounds |
| 08/23/2000 | CN1264306A Method for treatment of diarrhea disease and removing special bacterial population |
| 08/23/2000 | CN1263945A American pig reproduction and respiratory syndrome (PRRS) virus and its use |
| 08/23/2000 | CN1263776A Detoxicating health-care tea |
| 08/23/2000 | CN1055702C Extraction of cell-bound protein from bordetella |
| 08/23/2000 | CN1055700C Therapeutic peptide derivatives |
| 08/23/2000 | CN1055697C Phospholipi derivatives containing higher elements of the Vth main group |
| 08/23/2000 | CN1055627C Broad-spectrum antibiotic and bateriostatic and preparing method thereof |
| 08/22/2000 | US6107482 Nitrogenous macrocyclic compounds |
| 08/22/2000 | US6107473 Kringle-related clone HTHBZ47 |
| 08/22/2000 | US6107464 iceA gene and related methods |
| 08/22/2000 | US6107461 Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use |
| 08/22/2000 | US6107458 Cyclic hexapeptides having antibiotic activity |
| 08/22/2000 | US6107457 Bcr-abl peptide having tyrosine from position 177 and/or tyrosine from position 283; suppresses induction of ras protein; anticarcinogenic agents for leukemia; enriching bone marrow stem cells prior to transplantation |
| 08/22/2000 | US6107327 Therapeutic treatment for HIV infection |
| 08/22/2000 | US6107316 Method for treating protozoal infections |
| 08/22/2000 | US6107315 Nervous system disorders |
| 08/22/2000 | US6107312 Bactericide |
| 08/22/2000 | US6107305 Antiproferative agent, antiinflammatory agents |
| 08/22/2000 | US6107302 Storage stable valaciclovir in anhydrous crystalline form; viricide against herpes virus |
| 08/22/2000 | US6107294 Nervous system and psychological disorders |
| 08/22/2000 | US6107291 Antiinflammatory agent |
| 08/22/2000 | US6107290 Non-crystalline cefuroxime axetil solid dispersant, process for preparing same and composition for oral administration thereof |
| 08/22/2000 | US6107288 Antiviral nucleoside combination |
| 08/22/2000 | US6107284 Water-soluble derivatives of epipodophyllotoxin, process for their preparation, their use as medicinal products and their intended use in anti-cancer treatments |
| 08/22/2000 | US6107281 Compounds and their combinations for the treatment of influenza infection |